Lymphatic Regeneration after Popliteal Lymph Node Excision and Implantation of Aligned Nanofibrillar Collagen Scaffolds: An Experimental Rabbit Model
Authors:
- José Luis CamposJosé Luis Campos
- Gemma PonsGPGemma Pons
- Ali M. Al-SakkafAAAli M. Al-Sakkaf
- Irene Laura LusettiILIrene Laura Lusetti
- Laura PiresLPLaura Pires
- Francisco Javier VelaFVFrancisco Javier Vela
- Elena RamosERElena Ramos
- Verónica CrisóstomoVCVerónica Crisóstomo
- Francisco Miguel Sánchez-MargalloFrancisco Miguel Sánchez-Margallo
- Elena AbellánEAElena Abellán
- Jaume MasiáJMJaume Masiá
Open Access
- 21 August 2024
- journal article
- research article
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 15 (8) , 235
Abstract
Lymphedema presents significant challenges to patients’ quality of life, prompting the exploration of innovative treatments, such as collagen scaffolds, aimed at treating and reducing the risk of lymphedema. We aimed to evaluate the preventive and therapeutic efficacy and the lymphangiogenic potential of implanted aligned nanofibrillar collagen scaffolds (BioBridgeTM) following the induction of secondary lymphedema in a rabbit model. Thirty rabbits were divided into treatment (G1), prevention (G2), and control (G3) groups. Secondary lymphedema was induced in all groups. BioBridgeTM implantation was performed in G2 and G1 on days 0 and 60, respectively. Follow-ups included hindlimb circumference measurements and indocyanine green lymphography at 0, 60, and 90 days. None of the study rabbits exhibited dermal backflow on day 0 before surgery. At 60 days, the incidence rates of dermal backflow in G1, G2, and G3 were 100%, 44.4%, and 90%, respectively. Furthermore, at 90 days, the incidence rates were 22.2%, 44.4%, and 90%, respectively. New linear lymphatic observation was seen in rabbits with resolved dermal backflow. The findings of this study demonstrated the capacity of BioBridgeTM scaffolds to induce new lymphatic vessel formation and reduce dermal backflow in secondary lymphedema in a rabbit model.Keywords
Funding Information
- Complementary Plan for Biotechnology Applied to Health (PRTR-C17. I1)
- Extremadura ERDF Operational Program 2021–2027 (PRTR-C17. I1)
This publication has 41 references indexed in Scilit:
- Enhancing lymphangiogenesis and lymphatic drainage to vascularized lymph nodes with nanofibrillar collagen scaffoldsJournal of Surgical Oncology, 2022
- Lymphatic regeneration after implantation of aligned nanofibrillar collagen scaffolds: Preliminary preclinical and clinical resultsJournal of Surgical Oncology, 2021
- Manual lymphatic drainage treatment for lymphedema: a systematic review of the literatureJournal of Cancer Survivorship, 2020
- The role of adjunct nanofibrillar collagen scaffold implantation in the surgical management of secondary lymphedema: Review of the literature and summary of initial pilot studiesJournal of Surgical Oncology, 2019
- Systematic review of lymphovenous anastomosis (LVA) for the treatment of lymphedemaMicrosurgery, 2017
- Outcomes of vascularized versus non‐vascularized lymph node transplant in animal models for lymphedema. Review of the literatureJournal of Surgical Oncology, 2016
- A randomized control study of treating secondary stage II breast cancer-related lymphoedema with free lymph node transferBreast Cancer Research and Treatment, 2016
- The modulation of endothelial cell morphology, function, and survival using anisotropic nanofibrillar collagen scaffoldsBiomaterials, 2013
- Guidelines for the Care and Use of Laboratory Animals in Biomedical ResearchCurrent Protocols in Pharmacology, 2012
- Microsurgery for treatment of peripheral lymphedema: Long‐term outcome and future perspectivesMicrosurgery, 2007